These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 9177967

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical applicability of antifungal susceptibility testing on non-Candida albicans species in hospitalized patients.
    Wong-Beringera A, Hindler J, Brankovic L, Muehlbauer L, Steele-Moore L.
    Diagn Microbiol Infect Dis; 2001 Jan; 39(1):25-31. PubMed ID: 11173188
    [Abstract] [Full Text] [Related]

  • 3. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
    Tumbarello M, Caldarola G, Tacconelli E, Morace G, Posteraro B, Cauda R, Ortona L.
    J Antimicrob Chemother; 1996 Oct; 38(4):691-9. PubMed ID: 8937963
    [Abstract] [Full Text] [Related]

  • 4. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC.
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
    Barbaro G, Barbarini G, Di Lorenzo G.
    Scand J Infect Dis; 1995 Nov; 27(6):613-7. PubMed ID: 8685642
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P, Lopez J, Grappin M, Bonnin A, Duong M, Waldner A, Buisson M, Camerlynck P, Portier H.
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Candidiasis at ICAAC.
    Barr D, Smart T.
    GMHC Treat Issues; 1995 Oct; 9(10):13. PubMed ID: 11362914
    [Abstract] [Full Text] [Related]

  • 16. Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection.
    Ben-Ami R, Olshtain-Pops K, Krieger M, Oren I, Bishara J, Dan M, Wiener-Well Y, Weinberger M, Zimhony O, Chowers M, Weber G, Potasman I, Chazan B, Kassis I, Shalit I, Block C, Keller N, Kontoyiannis DP, Giladi M, Israeli Candidemia Study Group.
    Antimicrob Agents Chemother; 2012 May; 56(5):2518-23. PubMed ID: 22314534
    [Abstract] [Full Text] [Related]

  • 17. Emerging Candida species isolated from renal transplant recipients: Species distribution and susceptibility profiles.
    Diba K, Makhdoomi K, Nasri E, Vaezi A, Javidnia J, Gharabagh DJ, Jazani NH, Reza Chavshin A, Badiee P, Badali H, Fakhim H.
    Microb Pathog; 2018 Dec; 125():240-245. PubMed ID: 30240817
    [Abstract] [Full Text] [Related]

  • 18. Azole resistance in neonatal intensive care units in Argentina.
    Giusiano G, Mangiaterra M, Rojas F, Gómez V.
    J Chemother; 2005 Jun; 17(3):347-50. PubMed ID: 16038532
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Antifungal susceptibility of Candida species isolated from patient with invasive fungal peritonitis and investigation on clinical breakpoints of itraconazole].
    Yamagishi Y, Terada M, Ohki E, Mikamo H.
    Jpn J Antibiot; 2009 Oct; 62(5):415-34. PubMed ID: 20055119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.